晚期喉癌患者的肿瘤缺氧与CD8+ T细胞浸润
回顾性队列研究纳入92例接受生物选择法治疗的III-IV期喉鳞状细胞癌患者,采用免疫组化检测CAIX和CD8+ T细胞。CAIX阳性肿瘤占14.1%,其CD8+ T细胞浸润显著低于CAIX阴性肿瘤(18 vs 32,P=.028)。CAIX/TIL联合分类与诱导化疗反应可能性及肿瘤缩小程度相关,作者认为其作为生物标志物需前瞻性评估。
要点
- CAIX阳性肿瘤占14.1%,其CD8+ T细胞浸润显著低于CAIX阴性肿瘤(18 vs 32,P=.028)。
- CAIX染色与肿瘤亚部位、分期及诱导化疗反应均无关(所有P>.05)。
- CAIX/TIL联合分类与诱导反应可能性及反应者肿瘤缩小>80%相关。
核心结论
- 在晚期喉鳞状细胞癌接受生物选择法的患者中,CAIX染色与CD8+ T细胞浸润减少相关。
- CAIX/TIL联合分类与诱导化疗反应的可能性及程度相关。
- CAIX状态及其他免疫与缺氧联合特征作为诱导反应和生存生物标志物的效用需前瞻性评估。
研究设计与样本
- 回顾性队列研究,纳入92例接受生物选择法治疗的III至IV期喉鳞状细胞癌患者,其中声门上型68例(73.9%)。
- 采用免疫组化检测CD8+ T细胞和CAIX,使用非参数检验和Kaplan-Meier生存分析。
主要发现
- CAIX阳性肿瘤13例(14.1%),其CD8+ T细胞浸润显著低于CAIX阴性肿瘤(18 vs 32,P=.028)。
- CAIX染色与肿瘤亚部位、分期及诱导化疗反应均无差异(所有P>.05)。
- CAIX/TIL联合分类与反应可能性显著相关,CAIX-/TIL[high]者反应可能性更低;在反应者中,该分类可预测更高程度的肿瘤缩小(>80%)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed correlations between tumor carbonic anhydrase IX (CAIX) staining, as a marker of tumor hypoxia, and CD8+ T-cell infiltration in a cohort of patients with advanced laryngeal squamous cell carcinoma undergoing a bioselection approach for definitive treatment. STUDY DESIGN: Retrospective cohort study. SETTING: Tertiary care hospital. METHODS: Patients with stage III to IV laryngeal squamous cell carcinoma treated under a bioselection paradigm were included. Immunohistochemistry for CD8+ T-cells and CAIX was performed. Nonparametric tests and Kaplan-Meier survival analyses were used to compare tumor CAIX status by clinicopathologic variables and CD8+ T-cell infiltration and to evaluate the role of CAIX and combination CAIX/tumor infiltrating lymphocytes (TIL) category on survival. RESULTS: Our cohort included 92 patients (n = 68 [73.9%] supraglottic). No difference in CAIX staining was seen by tumor subsite, stage, and response to induction chemotherapy (all P > .05). Thirteen (14.1%) tumors were CAIX-positive and showed significantly lower CD8+ T-cell infiltration than CAIX-negative tumors (18 [0-62] vs 32 [0-399], P = .028). Combination CAIX/TIL category was significantly associated with the likelihood of response (CAIX-/TIL[high] were less likely to respond) and in the group of responders, was predictive of a higher degree of tumor shrinkage (>80%). CONCLUSION: CAIX staining correlates with reduced CD8+ T-cell infiltration in patients with advanced laryngeal squamous cell carcinoma undergoing bioselection. The combination CAIX/TIL category is associated with the likelihood and degree of response to induction. The utility of CAIX status and other combination immune and hypoxia signatures as a biomarker of induction response and survival merits prospective evaluation.
引用
- Smith JD, Gensterblum-Miller E, Forner DWA, et al. Tumor Hypoxia and CD8+ T-Cell Infiltration in Patients With Advanced Laryngeal Cancer. Otolaryngol Head Neck Surg. 2025. PMID: 40323140. doi:10.1002/ohn.1291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。